Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Soluble lymphotoxin-.beta. receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease

Soluble lymphotoxin-.beta. receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease

US Patent 5925351 · Granted Jul 20, 1999

Estimated economic value: $139,134,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-VLA-4 related assays2025
Grid coatings for capture of proteins and other compounds2024
Anti-VLA-4 related assays2022
Grid coatings for capture of proteins and other compounds2021
Methods of modulating immune responses using BCMA polypeptide2019
Anti-VLA-4 related assays2019
Anti-VLA-4 related assays2017
Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA)2017
Anti-VLA-4 related assays2016
Polymer conjugates of interferon beta-1A and uses2016
Methods of screening for a compound that inhibits the interaction between BAFF a2014
Method for increasing expression of active tumor necrosis factor receptor family2014